Seminal Vesicle Involvement by Carcinoma In Situ of the Bladder: Clonal Analysis Using Next-Generation Sequencing to Elucidate the Mechanism of Tumor Spread
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We present a rare case of urothelial carcinoma in situ (CIS), which invades the prostate and seminal vesicle (SV). A 70-year-old man underwent transurethral resection of bladder (TURB), and the pathologic examination revealed multiple CIS. Although the patient received intravesical bacillus Calmette-Guerin (BCG) therapy following TURB, recurrence of CIS was confirmed in the bladder and left distal ureter at 3 months following BCG. Radical cystectomy was performed due to BCG-refractory CIS. Microscopically, CIS was found throughout the mucosa of the bladder, left ureter, prostatic duct, and both SVs. Next-generation sequencing revealed significant differences in tumor clonality between bladder and SV CIS cells. Among 101 (bladder CIS) and 95 (SV CIS) somatic mutations, only two were shared, and only one gene (ARHGAP23) was common exon coding region gene. In conclusion, multicentric genetic changes, in line with the field-cancerization effect, may result in SV involvement by CIS of the bladder.
Abstract
We present a rare case of urothelial carcinoma in situ (CIS), which invades the prostate and seminal vesicle (SV). A 70-year-old man underwent transurethral resection of bladder (TURB), and the pathologic examination revealed multiple CIS. Although the patient received intravesical bacillus Calmette-Guerin (BCG) therapy following TURB, recurrence of CIS was confirmed in the bladder and left distal ureter at 3 months following BCG. Radical cystectomy was performed due to BCG-refractory CIS. Microscopically, CIS was found throughout the mucosa of the bladder, left ureter, prostatic duct, and both SVs. Next-generation sequencing revealed significant differences in tumor clonality between bladder and SV CIS cells. Among 101 (bladder CIS) and 95 (SV CIS) somatic mutations, only two were shared, and only one gene (ARHGAP23) was common exon coding region gene. In conclusion, multicentric genetic changes, in line with the field-cancerization effect, may result in SV involvement by CIS of the bladder.
참고문헌 (15)
- Global Burden of Disease Cancer Collaboration, "Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study", JAMA Oncol, 3, pp.524~548 (2017)
- Babjuk M, "EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder : update 2016", Eur Urol, 71, pp.447~461 (2017)
- Daneshmand S, "Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder", J Urol, 172, pp.81~84 (2004)
- Volkmer BG, "Outcome in patients with seminal vesicle invasion after radical cystectomy", J Urol, 169, pp.1299~1302 (2003)
- Montie JE, "Transitional cell carcinoma in situ of the seminal vesicles : 8 cases with discussion of pathogenesis, and clinical and biological implications", J Urol, 158, pp.1895~1898 (1997)
- Ro JY, "Seminal vesicle involvement by in situ and invasive transitional cell carcinoma of the bladder", Am J Surg Pathol, 11, pp.951~958 (1987)
- Jakse G, "Carcinoma in situ of the bladder extending into the seminal vesicles", J Urol, 137, pp.44~45 (1987)
- 최송이, "Seminal Vesicle Involvement by Urothelial Carcinoma in Situ of the Bladder with Mucosal Spread Pattern: A Case Report", Investigative and Clinical Urology, 53(5), pp.368~370 (2012), 대한비뇨의학회[DOI]
- Pietzak EJ, "Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets", Eur Urol, 72, pp.952~959 (2017)
- Cibulskis K, "Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples", Nat Bio-technol, 31, pp.213~219 (2013)
- Kiemeney LA, "Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer", J Urol, 150, pp.60~64 (1993)
- Sidransky D, "Clonal origin of bladder cancer", N Engl J Med, 326, pp.737~740 (1992)
- Harris AL, "Bladder cancer : field versus clonal origin", N Engl J Med, 326, pp.759~761 (1992)
- Habuchi T, "Metachronous multifocal development of urothelial cancers by intraluminal seeding", Lancet, 342, pp.1087~1088 (1993)
- Jones TD, "Molecular evidence supporting field effect in urothelial carcinogenesis", Clin Cancer Res, 11, pp.6512~6519 (2005)